How the LRC-TriCEPS™ technology works

Video how the LRC-TriCEPS™ technology works

LRC-TriCEPS™  is a novel approach which enables the identification of cell surface receptors and off-targets on the living cells for a wide range of orphan ligands, such as:

  • Peptides
  • Protein
  • Antibodies
  • Engineered affinity binders
  • Viruses

Watch the video to see how the LRC-TriCEPS™ technology works


  • BioMed
  • Follicum
  • Igenica Biotherapeutics
  • QIMR Berghofer
  • University of Miami
  • Münster University Hospital
  • University of Manitoba
  • The Rockefeller University
  • Medizinische Hochschule Hannover
  • Igenica Biotherapeutics (USA)
  • University of California San Francisco (UCSF)
  • CEDOC – Centro de Estudos de Doenças Crónicas
  • Washington University School of Medicine

More details to all testimonials